Roche Diagnostics Corporation Confirm Anti-Cd20 (L26) Pab

Roche Diagnostics Corporation confirm anti-cd20 (l26) pab; this antibody is intended for in vitro diagnostic (ivd) use. ventana medical systems, inc. (ventana) confirm anti-cd2 (l26) primary antibody is a mouse monoclonal antibody (igg2a, kappa) directed against an epitope present on human b lymphocytes. this antibody is intended for use to qualitatively identify cells of b lymphocytic lineage1 by light microscopy in sections of formalin fixed, paraffin embedded tissue on a ventana automated slide stainer. the clinical interpretation of any staining, or the absence of staining, must be complemented by morphological studies and evaluation of proper controls. evaluation must be made by a qualified pathologist within the context of the patients clinical history and other diagnostic tests. - ROCHMSD (Additional S&H or Hazmat Fees May Apply)